|
Volumn 458, Issue 7236, 2009, Pages 270-
|
Roche vows to keep Genentech culture
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
BIOTECHNOLOGY;
DRUG INDUSTRY;
DRUG MANUFACTURE;
GENETIC ENGINEERING;
NOTE;
PRIORITY JOURNAL;
BIOTECHNOLOGY;
CREATIVENESS;
DRUG INDUSTRY;
HUMANS;
INVESTMENTS;
RESEARCH PERSONNEL;
SAN FRANCISCO;
SWITZERLAND;
|
EID: 62649134704
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/458270a Document Type: Note |
Times cited : (1)
|
References (0)
|